Report overview
Preclinical In-vivo Imaging System is a collective name for various types of remote sensor systems that acquire non-photographic remote sensing images of ground objects. Scanning is usually used to allow the observer to observe the conditions in the human or animal body.
This report contains market size and forecasts of Preclinical In-vivo Imaging System in global, including the following market information:
Global Preclinical In-vivo Imaging System Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Preclinical In-vivo Imaging System Market Sales, 2017-2022, 2023-2028, (Units)
Global top five Preclinical In-vivo Imaging System companies in 2021 (%)
The global Preclinical In-vivo Imaging System market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Optical Imaging System Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Preclinical In-vivo Imaging System include Siemens A.G., General Electric(GE), Agilent Technologies, FUJIFILM VisualSonics, Aspect Imaging, Biospace Lab SA, Bruker Corporation, LI-COR Biosciences and Mesoso Ltd., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Preclinical In-vivo Imaging System manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Preclinical In-vivo Imaging System Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Preclinical In-vivo Imaging System Market Segment Percentages, by Type, 2021 (%)
Optical Imaging System
Nuclear Imaging System
Micro MRI System
Micro CT System
Micro Ultrasound System
Photoacoustic and Magnetic Particle Imaging Systems
Global Preclinical In-vivo Imaging System Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Preclinical In-vivo Imaging System Market Segment Percentages, by Application, 2021 (%)
Hospitals
Veterinary Clinics
Laboratory
Other
Global Preclinical In-vivo Imaging System Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Preclinical In-vivo Imaging System Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Preclinical In-vivo Imaging System revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Preclinical In-vivo Imaging System revenues share in global market, 2021 (%)
Key companies Preclinical In-vivo Imaging System sales in global market, 2017-2022 (Estimated), (Units)
Key companies Preclinical In-vivo Imaging System sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Siemens A.G.
General Electric(GE)
Agilent Technologies
FUJIFILM VisualSonics
Aspect Imaging
Biospace Lab SA
Bruker Corporation
LI-COR Biosciences
Mesoso Ltd.
MIlabs BV
MR Solutions Ltd
PerkinElmer
TriFoil Imaging
